DEF 14A

Company

Chemomab Therapeutics Ltd.

Filed

January 5, 2022

Period of Report

January 5, 2022

Accession Number

0001178913-22-000040

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →